A new CT injection system promises unprecedented performance, according to its developer Medrad. The Stellant Injection System features saline flush, a pressure monitor graph, improved syringe design, syringe autoload, and the ability to upgrade from
A new CT injection system promises unprecedented performance, according to its developer Medrad. The Stellant Injection System features saline flush, a pressure monitor graph, improved syringe design, syringe autoload, and the ability to upgrade from single to dual injection. Its ability to precisely deliver contrast fluid under multiple CT protocols matches the speed of the new class of multidetector CT scanners. Stellant is considered especially suited to trauma, angiography, and cardiology exams, which incorporate demanding protocols with saline flush capability.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.